array(40) {
  [0]=>
  string(4) "8777"
  ["article_id"]=>
  string(4) "8777"
  [1]=>
  string(61) "Younger Onset of T2DM Tied to Poorer Initial Glycemic Control"
  ["article_title"]=>
  string(61) "Younger Onset of T2DM Tied to Poorer Initial Glycemic Control"
  [2]=>
  string(150) "FRIDAY, April 10, 2020 -- Adults diagnosed with type 2 diabetes between the ages of 21 and 44 years have higher initial hemoglobin A1c (HbA1c) levels "
  ["short_description"]=>
  string(150) "FRIDAY, April 10, 2020 -- Adults diagnosed with type 2 diabetes between the ages of 21 and 44 years have higher initial hemoglobin A1c (HbA1c) levels "
  [3]=>
  string(250) "FRIDAY, April 10, 2020 -- Adults diagnosed with type 2 diabetes between the ages of 21 and 44 years have higher initial hemoglobin A1c (HbA1c) levels and a lower likelihood of achieving glycemic control within one year of diagnosis versus patients..."
  ["description"]=>
  string(250) "FRIDAY, April 10, 2020 -- Adults diagnosed with type 2 diabetes between the ages of 21 and 44 years have higher initial hemoglobin A1c (HbA1c) levels and a lower likelihood of achieving glycemic control within one year of diagnosis versus patients..."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(1) "6"
  ["rss_id"]=>
  string(1) "6"
  [14]=>
  string(198) "https://www.drugs.com/news/younger-onset-t2dm-tied-poorer-initial-glycemic-control-89534.html?utm_source=ddc&utm_medium=rss&utm_campaign=Younger+Onset+of+T2DM+Tied+to+Poorer+Initial+Glycemic+Control"
  ["blog_url"]=>
  string(198) "https://www.drugs.com/news/younger-onset-t2dm-tied-poorer-initial-glycemic-control-89534.html?utm_source=ddc&utm_medium=rss&utm_campaign=Younger+Onset+of+T2DM+Tied+to+Poorer+Initial+Glycemic+Control"
  [15]=>
  string(19) "2020-04-10 20:04:13"
  ["add_date"]=>
  string(19) "2020-04-10 20:04:13"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2020-04-12 16:36:38"
  ["create_at"]=>
  string(19) "2020-04-12 16:36:38"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "8778"
  ["article_id"]=>
  string(4) "8778"
  [1]=>
  string(73) "Anxiety Up for Nonmedical Health Care Workers Versus Those on Front Lines"
  ["article_title"]=>
  string(73) "Anxiety Up for Nonmedical Health Care Workers Versus Those on Front Lines"
  [2]=>
  string(150) "FRIDAY, April 10, 2020 -- Non-medically trained health care workers caring for patients with coronavirus disease 2019 (COVID-19) have an increased pre"
  ["short_description"]=>
  string(150) "FRIDAY, April 10, 2020 -- Non-medically trained health care workers caring for patients with coronavirus disease 2019 (COVID-19) have an increased pre"
  [3]=>
  string(248) "FRIDAY, April 10, 2020 -- Non-medically trained health care workers caring for patients with coronavirus disease 2019 (COVID-19) have an increased prevalence of anxiety compared with medically trained health care workers, according to a research..."
  ["description"]=>
  string(248) "FRIDAY, April 10, 2020 -- Non-medically trained health care workers caring for patients with coronavirus disease 2019 (COVID-19) have an increased prevalence of anxiety compared with medically trained health care workers, according to a research..."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(1) "6"
  ["rss_id"]=>
  string(1) "6"
  [14]=>
  string(221) "https://www.drugs.com/news/anxiety-up-nonmedical-health-care-workers-versus-those-front-lines-89539.html?utm_source=ddc&utm_medium=rss&utm_campaign=Anxiety+Up+for+Nonmedical+Health+Care+Workers+Versus+Those+on+Front+Lines"
  ["blog_url"]=>
  string(221) "https://www.drugs.com/news/anxiety-up-nonmedical-health-care-workers-versus-those-front-lines-89539.html?utm_source=ddc&utm_medium=rss&utm_campaign=Anxiety+Up+for+Nonmedical+Health+Care+Workers+Versus+Those+on+Front+Lines"
  [15]=>
  string(19) "2020-04-10 20:04:00"
  ["add_date"]=>
  string(19) "2020-04-10 20:04:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2020-04-12 16:36:38"
  ["create_at"]=>
  string(19) "2020-04-12 16:36:38"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "8842"
  ["article_id"]=>
  string(4) "8842"
  [1]=>
  string(92) "Zynerba Pharmaceuticals to Present at the 19th Annual Needham Virtual Healthcare Conference "
  ["article_title"]=>
  string(92) "Zynerba Pharmaceuticals to Present at the 19th Annual Needham Virtual Healthcare Conference "
  [2]=>
  string(150) "DEVON, Pa., April  10, 2020  (GLOBE NEWSWIRE) -- Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE), the leader in innovative pharmaceutically-produced trans"
  ["short_description"]=>
  string(150) "DEVON, Pa., April  10, 2020  (GLOBE NEWSWIRE) -- Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE), the leader in innovative pharmaceutically-produced trans"
  [3]=>
  string(892) "
DEVON, Pa., April  10, 2020  (GLOBE NEWSWIRE) -- Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE), the leader in innovative pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders, today announced that Zynerba’s Chief Executive Officer, Armando Anido will present a company overview at the 19th Annual Needham Virtual Healthcare Conference. The presentation will take place on Wednesday April 15, 2020 at 2:50PM ET. This meeting is being held virtually, and a live webcast of the presentation will be accessible on the Investor Relations page of http://www.zynerba.com. 
"
  ["description"]=>
  string(892) "
DEVON, Pa., April  10, 2020  (GLOBE NEWSWIRE) -- Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE), the leader in innovative pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders, today announced that Zynerba’s Chief Executive Officer, Armando Anido will present a company overview at the 19th Annual Needham Virtual Healthcare Conference. The presentation will take place on Wednesday April 15, 2020 at 2:50PM ET. This meeting is being held virtually, and a live webcast of the presentation will be accessible on the Investor Relations page of http://www.zynerba.com. 
"
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "25"
  ["rss_id"]=>
  string(2) "25"
  [14]=>
  string(162) "http://www.globenewswire.com/news-release/2020/04/10/2014789/0/en/Zynerba-Pharmaceuticals-to-Present-at-the-19th-Annual-Needham-Virtual-Healthcare-Conference.html"
  ["blog_url"]=>
  string(162) "http://www.globenewswire.com/news-release/2020/04/10/2014789/0/en/Zynerba-Pharmaceuticals-to-Present-at-the-19th-Annual-Needham-Virtual-Healthcare-Conference.html"
  [15]=>
  string(19) "2020-04-10 20:00:00"
  ["add_date"]=>
  string(19) "2020-04-10 20:00:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2020-04-12 16:41:54"
  ["create_at"]=>
  string(19) "2020-04-12 16:41:54"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "8761"
  ["article_id"]=>
  string(4) "8761"
  [1]=>
  string(56) "Heart Patients Should Ask About Home-Based Cardiac Rehab"
  ["article_title"]=>
  string(56) "Heart Patients Should Ask About Home-Based Cardiac Rehab"
  [2]=>
  string(150) "FRIDAY, April 10, 2020 -- For those with heart problems, home-based rehab can take the place of hospital-based cardiac rehabilitation during the curre"
  ["short_description"]=>
  string(150) "FRIDAY, April 10, 2020 -- For those with heart problems, home-based rehab can take the place of hospital-based cardiac rehabilitation during the curre"
  [3]=>
  string(251) "FRIDAY, April 10, 2020 -- For those with heart problems, home-based rehab can take the place of hospital-based cardiac rehabilitation during the current coronavirus pandemic, heart experts say.&#nl"Home-based cardiac rehab is a solution to help..."
  ["description"]=>
  string(251) "FRIDAY, April 10, 2020 -- For those with heart problems, home-based rehab can take the place of hospital-based cardiac rehabilitation during the current coronavirus pandemic, heart experts say.&#nl"Home-based cardiac rehab is a solution to help..."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(1) "5"
  ["rss_id"]=>
  string(1) "5"
  [14]=>
  string(188) "https://www.drugs.com/news/heart-patients-should-ask-home-based-cardiac-rehab-89527.html?utm_source=ddc&utm_medium=rss&utm_campaign=Heart+Patients+Should+Ask+About+Home-Based+Cardiac+Rehab"
  ["blog_url"]=>
  string(188) "https://www.drugs.com/news/heart-patients-should-ask-home-based-cardiac-rehab-89527.html?utm_source=ddc&utm_medium=rss&utm_campaign=Heart+Patients+Should+Ask+About+Home-Based+Cardiac+Rehab"
  [15]=>
  string(19) "2020-04-10 17:04:32"
  ["add_date"]=>
  string(19) "2020-04-10 17:04:32"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2020-04-12 16:36:37"
  ["create_at"]=>
  string(19) "2020-04-12 16:36:37"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "8965"
  ["article_id"]=>
  string(4) "8965"
  [1]=>
  string(34) "Guidelines released on USAN naming"
  ["article_title"]=>
  string(34) "Guidelines released on USAN naming"
  [2]=>
  string(150) "The American Medical Association (AMA) has issued guidelines on naming using United States Adopted Names (USAN), which are unique non-proprietary name"
  ["short_description"]=>
  string(150) "The American Medical Association (AMA) has issued guidelines on naming using United States Adopted Names (USAN), which are unique non-proprietary name"
  [3]=>
  string(202) "
The American Medical Association (AMA) has issued guidelines on naming using United States Adopted Names (USAN), which are unique non-proprietary names assigned to pharmaceuticals sold in the US.
"
  ["description"]=>
  string(202) "
The American Medical Association (AMA) has issued guidelines on naming using United States Adopted Names (USAN), which are unique non-proprietary names assigned to pharmaceuticals sold in the US.
"
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "42"
  ["rss_id"]=>
  string(2) "42"
  [14]=>
  string(72) "http://www.gabionline.net//Guidelines/Guidelines-released-on-USAN-naming"
  ["blog_url"]=>
  string(72) "http://www.gabionline.net//Guidelines/Guidelines-released-on-USAN-naming"
  [15]=>
  string(19) "2020-04-10 16:29:06"
  ["add_date"]=>
  string(19) "2020-04-10 16:29:06"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2020-04-12 16:42:22"
  ["create_at"]=>
  string(19) "2020-04-12 16:42:22"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "8966"
  ["article_id"]=>
  string(4) "8966"
  [1]=>
  string(50) " Clinical trials for adalimumab biosimilar ABP 501"
  ["article_title"]=>
  string(50) " Clinical trials for adalimumab biosimilar ABP 501"
  [2]=>
  string(158) "&#nlThe clinical trials used to support the approval of Amgen’s ABP 501 (Amjevita/Amgevita/Solymbic) were critically reviewed by authors from Arge"
  ["short_description"]=>
  string(158) "&#nlThe clinical trials used to support the approval of Amgen’s ABP 501 (Amjevita/Amgevita/Solymbic) were critically reviewed by authors from Arge"
  [3]=>
  string(192) "
&#nlThe clinical trials used to support the approval of Amgen’s ABP 501 (Amjevita/Amgevita/
Solymbic) were critically reviewed by authors from Argentina and the UK [1].
"
  ["description"]=>
  string(192) "
&#nlThe clinical trials used to support the approval of Amgen’s ABP 501 (Amjevita/Amgevita/
Solymbic) were critically reviewed by authors from Argentina and the UK [1].
"
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "42"
  ["rss_id"]=>
  string(2) "42"
  [14]=>
  string(97) "http://www.gabionline.net//Biosimilars/Research/Clinical-trials-for-adalimumab-biosimilar-ABP-501"
  ["blog_url"]=>
  string(97) "http://www.gabionline.net//Biosimilars/Research/Clinical-trials-for-adalimumab-biosimilar-ABP-501"
  [15]=>
  string(19) "2020-04-10 16:25:32"
  ["add_date"]=>
  string(19) "2020-04-10 16:25:32"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2020-04-12 16:42:22"
  ["create_at"]=>
  string(19) "2020-04-12 16:42:22"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "8967"
  ["article_id"]=>
  string(4) "8967"
  [1]=>
  string(61) "Non-originator biologicals approved in Bosnia and Herzegovina"
  ["article_title"]=>
  string(61) "Non-originator biologicals approved in Bosnia and Herzegovina"
  [2]=>
  string(150) "Russian biotechnology company Biocad announced on 30 March 2020 that it had received approval for two of its anticancer non-originator biologicals in "
  ["short_description"]=>
  string(150) "Russian biotechnology company Biocad announced on 30 March 2020 that it had received approval for two of its anticancer non-originator biologicals in "
  [3]=>
  string(180) "
Russian biotechnology company Biocad announced on 30 March 2020 that it had received approval for two of its anticancer non-originator biologicals in Bosnia and Herzegovina.
"
  ["description"]=>
  string(180) "
Russian biotechnology company Biocad announced on 30 March 2020 that it had received approval for two of its anticancer non-originator biologicals in Bosnia and Herzegovina.
"
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "42"
  ["rss_id"]=>
  string(2) "42"
  [14]=>
  string(105) "http://www.gabionline.net//Biosimilars/News/Non-originator-biologicals-approved-in-Bosnia-and-Herzegovina"
  ["blog_url"]=>
  string(105) "http://www.gabionline.net//Biosimilars/News/Non-originator-biologicals-approved-in-Bosnia-and-Herzegovina"
  [15]=>
  string(19) "2020-04-10 16:21:49"
  ["add_date"]=>
  string(19) "2020-04-10 16:21:49"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2020-04-12 16:42:22"
  ["create_at"]=>
  string(19) "2020-04-12 16:42:22"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "8968"
  ["article_id"]=>
  string(4) "8968"
  [1]=>
  string(45) "Biocure developing five candidate biosimilars"
  ["article_title"]=>
  string(45) "Biocure developing five candidate biosimilars"
  [2]=>
  string(155) "South Korea’s pharmaceutical industry has fast been expanding as a world player. According to the Korea Health Industry Development Institute, the K"
  ["short_description"]=>
  string(155) "South Korea’s pharmaceutical industry has fast been expanding as a world player. According to the Korea Health Industry Development Institute, the K"
  [3]=>
  string(273) "
South Korea’s pharmaceutical industry has fast been expanding as a world player. According to the Korea Health Industry Development Institute, the Korean pharmaceutical industry in 2018 represented 1.8% of the world market, i.e. the 13th largest in the world.
"
  ["description"]=>
  string(273) "
South Korea’s pharmaceutical industry has fast been expanding as a world player. According to the Korea Health Industry Development Institute, the Korean pharmaceutical industry in 2018 represented 1.8% of the world market, i.e. the 13th largest in the world.
"
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "42"
  ["rss_id"]=>
  string(2) "42"
  [14]=>
  string(92) "http://www.gabionline.net//Biosimilars/General/Biocure-developing-five-candidate-biosimilars"
  ["blog_url"]=>
  string(92) "http://www.gabionline.net//Biosimilars/General/Biocure-developing-five-candidate-biosimilars"
  [15]=>
  string(19) "2020-04-10 16:19:35"
  ["add_date"]=>
  string(19) "2020-04-10 16:19:35"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2020-04-12 16:42:22"
  ["create_at"]=>
  string(19) "2020-04-12 16:42:22"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "8762"
  ["article_id"]=>
  string(4) "8762"
  [1]=>
  string(33) "Health Highlights: April 10, 2020"
  ["article_title"]=>
  string(33) "Health Highlights: April 10, 2020"
  [2]=>
  string(153) "Here are some of the latest health and medical news developments, compiled by the editors of HealthDay:&#nlNo Sail Order For Cruise Ships Extended by CDC"
  ["short_description"]=>
  string(153) "Here are some of the latest health and medical news developments, compiled by the editors of HealthDay:&#nlNo Sail Order For Cruise Ships Extended by CDC"
  [3]=>
  string(250) "Here are some of the latest health and medical news developments, compiled by the editors of HealthDay:&#nlNo Sail Order For Cruise Ships Extended by CDC&#nlA No Sail Order for all cruise ships was extended Thursday by the U.S. Centers for Disease..."
  ["description"]=>
  string(250) "Here are some of the latest health and medical news developments, compiled by the editors of HealthDay:&#nlNo Sail Order For Cruise Ships Extended by CDC&#nlA No Sail Order for all cruise ships was extended Thursday by the U.S. Centers for Disease..."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(1) "5"
  ["rss_id"]=>
  string(1) "5"
  [14]=>
  string(150) "https://www.drugs.com/news/health-highlights-april-10-2020-89528.html?utm_source=ddc&utm_medium=rss&utm_campaign=Health+Highlights%3A+April+10%2C+2020"
  ["blog_url"]=>
  string(150) "https://www.drugs.com/news/health-highlights-april-10-2020-89528.html?utm_source=ddc&utm_medium=rss&utm_campaign=Health+Highlights%3A+April+10%2C+2020"
  [15]=>
  string(19) "2020-04-10 16:04:35"
  ["add_date"]=>
  string(19) "2020-04-10 16:04:35"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2020-04-12 16:36:37"
  ["create_at"]=>
  string(19) "2020-04-12 16:36:37"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "8843"
  ["article_id"]=>
  string(4) "8843"
  [1]=>
  string(94) "COVID-19:  Sanofi to donate 100 million doses of hydroxychloroquine across 50 countries "
  ["article_title"]=>
  string(94) "COVID-19:  Sanofi to donate 100 million doses of hydroxychloroquine across 50 countries "
  [2]=>
  string(94) "COVID-19:  Sanofi to donate 100 million doses of hydroxychloroquine across 50 countries "
  ["short_description"]=>
  string(94) "COVID-19:  Sanofi to donate 100 million doses of hydroxychloroquine across 50 countries "
  [3]=>
  string(135) "
COVID-19:  Sanofi to donate 100 million doses of hydroxychloroquine across 50 countries 
"
  ["description"]=>
  string(135) "
COVID-19:  Sanofi to donate 100 million doses of hydroxychloroquine across 50 countries 
"
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "25"
  ["rss_id"]=>
  string(2) "25"
  [14]=>
  string(156) "http://www.globenewswire.com/news-release/2020/04/10/2014764/0/en/COVID-19-Sanofi-to-donate-100-million-doses-of-hydroxychloroquine-across-50-countries.html"
  ["blog_url"]=>
  string(156) "http://www.globenewswire.com/news-release/2020/04/10/2014764/0/en/COVID-19-Sanofi-to-donate-100-million-doses-of-hydroxychloroquine-across-50-countries.html"
  [15]=>
  string(19) "2020-04-10 13:55:00"
  ["add_date"]=>
  string(19) "2020-04-10 13:55:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2020-04-12 16:41:54"
  ["create_at"]=>
  string(19) "2020-04-12 16:41:54"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}